These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 11888589)

  • 41. [Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: a case report].
    Takahashi M; Toru S; Ota K; Izumiyama H; Yokota T; Mizusawa H
    Rinsho Shinkeigaku; 2008 Feb; 48(2):120-4. PubMed ID: 18326305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors.
    Schillaci O; Scopinaro F; Angeletti S; Tavolaro R; Danieli R; Annibale B; Gualdi G; Delle Fave G
    J Nucl Med; 1996 Sep; 37(9):1452-6. PubMed ID: 8790191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Somatostatin receptor scintigraphy in gastrinomas.
    Jensen RT; Gibril F
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S179-85. PubMed ID: 10604126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [111In-pentetreotide in the study of tumors expressing somatostatin receptors].
    Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R
    Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.
    Kim I; Rajani R
    J Foot Ankle Surg; 2016; 55(2):294-8. PubMed ID: 25441266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The current status of somatostatin receptors in malignant melanoma.
    Fletcher WS; Lum SS; Nance RW; Pommier RF; O'Dorisio MS
    Yale J Biol Med; 1997; 70(5-6):561-3. PubMed ID: 9825484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings.
    Shustik DA; Ng DC; Sittampalam K
    Int J Clin Exp Pathol; 2015; 8(6):7506-17. PubMed ID: 26261662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma.
    Tenenbaum F; Lumbroso J; Schlumberger M; Caillou B; Fragu P; Parmentier C
    J Nucl Med; 1995 May; 36(5):807-10. PubMed ID: 7738653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumour-induced osteomalacia due to residual benign glomangioma.
    Barai R; Tsang T; Cespedes L
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36357106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor.
    Meyers MO; Anthony LB; McCarthy KE; Drouant G; Maloney TJ; Espanan GD; Woltering EA
    South Med J; 2000 Aug; 93(8):809-11. PubMed ID: 10963516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography.
    Hesse E; Moessinger E; Rosenthal H; Laenger F; Brabant G; Petrich T; Gratz KF; Bastian L
    J Bone Miner Res; 2007 Jan; 22(1):158-62. PubMed ID: 17014386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
    Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
    G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic performance and impact on patient management of
    Paquet M; Gauthé M; Zhang Yin J; Nataf V; Bélissant O; Orcel P; Roux C; Talbot JN; Montravers F
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1710-1720. PubMed ID: 29532101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. False-positive somatostatin receptor scintigraphy due to an accessory spleen.
    Lebtahi R; Cadiot G; Marmuse JP; Vissuzaine C; Petegnief Y; Courillon-Mallet A; Cattan D; Mignon M; Le Guludec D
    J Nucl Med; 1997 Dec; 38(12):1979-81. PubMed ID: 9430481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oncogenic osteomalacia: localization of underlying peripheral mesenchymal tumors with use of Tc 99m sestamibi scintigraphy.
    Hodgson SF; Clarke BL; Tebben PJ; Mullan BP; Cooney WP; Shives TC
    Endocr Pract; 2006; 12(1):35-42. PubMed ID: 16524861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oncogenic Osteomalacia Secondary to a Metastatic Phosphaturic Mesenchymal Tumor in the Talus: A Case Report and Review of the Literature.
    Aziz KT; McCarthy EF; Morris CD
    JBJS Case Connect; 2017; 7(2):e40. PubMed ID: 29244678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues.
    Chiti A; van Graafeiland BJ; Savelli G; Ferrari L; Seregni E; Castellani MR; Bombardieri E
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S190-4. PubMed ID: 10604128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors.
    Briganti V; Sestini R; Orlando C; Bernini G; La Cava G; Tamburini A; Raggi CC; Serio M; Maggi M
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2385-91. PubMed ID: 9815638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI.
    Lee JD; Kim DI; Lee JT; Chang JW; Park CY
    J Nucl Med; 1995 Apr; 36(4):537-41. PubMed ID: 7699438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extended curettage for tumour-induced osteomalacia in the bone.
    Okajima K; Kobayashi H; Ito N; Kato H; Ishibashi Y; Zhang L; Tsuda Y; Tanaka S
    Jpn J Clin Oncol; 2024 Apr; 54(4):463-470. PubMed ID: 38266040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.